ArticleClinical cancer research : an official journal of the American Association for Cancer Research2016

Hypoxia-Activated Prodrug TH-302 Targets Hypoxic Bone Marrow Niches in Preclinical Leukemia Models.

Juliana Benito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.